Design Therapeutics Inc (DSGN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Joao Siffert
Employees:
40
991C LOMAS SANTA FE #436, SOLANA BEACH, CA 92121
858-293-4900

Design Therapeutics, Inc. engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction. It is also developing GeneTAC product candidate portfolio for the. treatment of other monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 432.159 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.14
Price to Revenue0.0 Debt to Equity0.0 EBITDA-57.14 Million
Price to Book Value2.7356 Operating Margin0.0 Enterprise Value588.448 Million
Current Ratio33.47 EPS Growth0.051 Quick Ratio33.061
1 Yr BETA 1.4874 52-week High/Low 26.3 / 6.94 Profit Margin0.0
Operating Cash Flow Growth-97.6733 Altman Z-Score41.2986 Free Cash Flow to Firm -39.923 Million
Earnings Report2023-03-09
View SEC Filings from DSGN instead.

View recent insider trading info

Design Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DSGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DSGN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.8 Million total shares from 9 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SIFFERT JOAO MD PRESIDENT AND CEO

  • Officer
  • Director
 132,619 2022-12-19 2

GEORGE SIMEON

  • Director
  • 10% Owner
 6,526,476 2022-12-16 2

SR ONE CAPITAL FUND I AGGREGATOR LP

SR ONE CAPITAL PARTNERS I, LP

SR ONE CAPITAL MANAGEMENT, LLC

  • 10% Owner
 6,526,476 2022-12-16 1

LAPPE RODNEY W

  • Director
 112,024 2022-12-09 2

SCHMID JOHN P.

  • Director
 15,000 2022-06-15 1

XU STELLA

  • Director
 15,000 2022-06-15 2

BERGER HEATHER A.

  • Director
 15,000 2022-06-15 1

WILLIAM ARSANI

  • Director
 15,000 2022-06-15 2

PRASAD DEEPA

  • Director
 15,000 2022-06-15 2

SHAH PRATIK EXECUTIVE CHAIRPERSON

  • Officer
  • Director
 475,000 2022-02-01 1

JEFFRIES SEAN CHIEF OPERATING OFFICER

  • Officer
 350,000 2022-02-01 1

BURGESS JULIE CHIEF ACCOUNTING OFFICER

  • Officer
 50,000 2022-02-01 1

GIANGIULIO DAWN PRINCIPAL ACCOUNTING OFFICER

  • Officer
 7,500 2021-08-13 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND II, LP

CORMORANT PRIVATE HEALTHCARE FUND III LP

  • Director
  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 No longer subject to file 2021-03-30 0

QUAN VENTURE FUND II, L.P.

  • 10% Owner
 4,720,830 2021-03-30 0

THACKER JUSTIN VICE PRESIDENT, FINANCE

  • Officer
 17,500 2021-03-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SR ONE CAPITAL FUND I AGGREGATOR LP - > 10% Owner

SR ONE CAPITAL PARTNERS I, LP - > 10% Owner

SR ONE CAPITAL MANAGEMENT, LLC - > 10% Owner

2022-12-20 18:37:12 -0500 2022-12-20 P 40,000 $8.14 a 6,526,476 direct 9.3051 21.3192 21.3192 6 0.0 1

GEORGE SIMEON - Director - > 10% Owner see note 2

2022-12-20 18:45:07 -0500 2022-12-20 P 40,000 $8.14 a 6,526,476 indirect 9.3051 21.3192 21.3192 6 0.0 1

SIFFERT JOAO MD - Director - Officer PRESIDENT AND CEO

2022-12-21 17:00:16 -0500 2022-12-20 P 6,300 $8.38 a 132,619 direct 2.694 10.5603 10.9914 5 -0.9698 3

SR ONE CAPITAL FUND I AGGREGATOR LP - > 10% Owner

SR ONE CAPITAL PARTNERS I, LP - > 10% Owner

SR ONE CAPITAL MANAGEMENT, LLC - > 10% Owner

2022-12-20 18:37:12 -0500 2022-12-19 P 360,000 $8.63 a 6,486,476 direct 9.3051 21.3192 21.3192 6 0.0 1

GEORGE SIMEON - Director - > 10% Owner see note 2

2022-12-20 18:45:07 -0500 2022-12-19 P 360,000 $8.63 a 6,486,476 indirect 9.3051 21.3192 21.3192 6 0.0 1

SIFFERT JOAO MD - Director - Officer PRESIDENT AND CEO

2022-12-21 17:00:16 -0500 2022-12-19 P 1,150 $8.47 a 126,319 direct 2.694 10.5603 10.9914 5 -0.9698 3

SR ONE CAPITAL FUND I AGGREGATOR LP - > 10% Owner

SR ONE CAPITAL PARTNERS I, LP - > 10% Owner

SR ONE CAPITAL MANAGEMENT, LLC - > 10% Owner

2022-12-20 18:37:12 -0500 2022-12-16 P 500,000 $8.28 a 6,126,476 direct 9.3051 21.3192 21.3192 6 0.0 1

GEORGE SIMEON - Director - > 10% Owner see note 2

2022-12-20 18:45:07 -0500 2022-12-16 P 500,000 $8.28 a 6,126,476 indirect 9.3051 21.3192 21.3192 6 0.0 1

LAPPE RODNEY W - Director

2022-12-12 17:22:40 -0500 2022-12-09 P 15,000 $7.96 a 112,024 direct -1.6611 -10.742 0.0 1 -10.742 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
DESIGN THERAPEUTICS INC DSGN 2023-01-26 22:15:03 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 21:45:03 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 21:15:04 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 20:45:03 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 20:15:04 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 19:45:03 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 19:15:04 UTC 2.625 1.695 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 18:45:03 UTC 2.625 1.695 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 18:15:04 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 17:45:04 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 17:15:04 UTC 2.625 1.695 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 16:45:03 UTC 2.4431 1.8769 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 16:15:04 UTC 2.4431 1.8769 300000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 15:45:03 UTC 2.4431 1.8769 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 15:15:04 UTC 2.4431 1.8769 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 14:45:04 UTC 1.9597 2.3603 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 14:15:03 UTC 1.9597 2.3603 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 13:45:03 UTC 1.9597 2.3603 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 13:15:04 UTC 1.9597 2.3603 250000
DESIGN THERAPEUTICS INC DSGN 2023-01-26 12:45:04 UTC 1.9597 2.3603 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund DSGN -1800.0 shares, $-30096.0 2022-09-30 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund DSGN -10171.0 shares, $-170059.12 2022-09-30 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund DSGN -535.0 shares, $-8356.7 2022-10-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments